跳至主要内容
临床试验/JPRN-jRCT1032220685
JPRN-jRCT1032220685招募中2 期

Efficacy and safety of gamma knife radiosurgery for asymptomatic intracranial hemangioblastoma in patients with von Hippel-Lindau disease: A prospective interventional trial

Hasegawa Hirotaka0 个研究点目标入组 20 人开始时间: 2023年3月3日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 < 80age old(—)
性别
All

入选标准

  • (1) With a diagnosis of Von Hippel-Lindau (VHL) disease based on clinical criteria of the VHL guideline (2017 edition)
  • (2) With intracranial hemangioblastomas detected by contrast-enhanced MRI without neurological symptoms
  • (3) Aged from 18 to 80 years at the time of informed consent is taken
  • (4) Male or female
  • (5) Able and willing to give written informed consent with sufficient understanding after having received sufficient explanation
  • (6) Able to attend all scheduled visits

排除标准

  • (1) With signs of cerebellar compression, requiring surgery
  • (2) With neurological symptoms
  • (3) With a large tumor, the maximum diameter of the tumor parenchyma of more than 25 mm
  • (4) With a large cystic tumor, the maximum diameter including cystic part of more than 30 mm
  • (5) Having chemotherapy for tumors except brain tumors
  • (6) Karnofsky Performance Score of less than 70
  • (7) With uncontrolled malignancy
  • (8) With severe liver failure or renal failure
  • (9) Unable to have MRI scans
  • (10) With severe abnormality in usual vital signs: systolic blood pressure of 200mmHg or more, diastolic blood pressure of 120 mmHg or more, SpO2 in room air of less than 90%, pulse rate of 120 bpm or more
  • (11) Judged as ineligible by clinical investigators

研究者

发起方
Hasegawa Hirotaka

相似试验